Research progress of obstructive sleep apnea hypopnea syndrome and coronary heart disease
HU Sixiong1 ZHANG Zheng1,2
1.The First School of Clinical Medical, the First Hospital of Lanzhou University, Gansu Province, Lanzhou 730000, China;
2.Department of Cardiology, the First Hospital of Lanzhou University, Gansu Province, Lanzhou 730000, China
Abstract：Obstructive sleep apnea hypopnea syndrome (OSAHS) is a chronic sleep disordered breathing disease which is increasingly common in adults. Sleep-disordered breathing plays an important role in the cardiovascular system, and OSAHS patients with coronary heart disease are also increasing. However, OSAHS is still unclear about the occurrence and development of coronary heart disease, and still considerable controversy in treatment. This article reviews the progress on the incidence, severity and prognosis of OSAHS and coronary heart disease.
[1] Heinzer R，Vat S，Marques-Vidal P，et al. Prevalence of sleep-disordered breathing in the general population：the HypnoLaus study [J]. Lancet Respir Med，2015，3（4）：310-318.
[2] Benjafield AV，Ayas NT，Eastwood PR，et al. Estimation of the global prevalence and burden of obstructive sleep apnoea：a literature-based analysis [J]. Lancet Respir Med，2019，7（8）：687-698.
[3] Zhang Z，Wang Q，Chen B，et al. Association study of genetic variations of inflammatory biomarkers with susceptibility and severity of obstructive sleep apnea [J]. Mol Genet Genomic Med，2019，7（8）：e801.
[4] Semenza GL，Prabhakar NR. Neural regulation of hypoxia-inducible factors and redox state drives the pathogenesis of hypertension in a rodent model of sleep apnea [J]. J Appl Physiol（1985），2015，119（10）：1152-1156.
[5] Lira AB，de Sousa Rodrigues CF. Evaluation of oxidative stress markers in obstructive sleep apnea syndrome and additional antioxidant therapy：a review article [J]. Sleep Breath，2016，20（4）：1155-1160.
[6] Tuleta I，Franca CN，Wenzel D，et al. Hypoxia-induced endothelial dysfunction in apolipoprotein E-deficient mice; effects of infliximab and L-glutathione [J]. Atherosclerosis，2014，236（2）：400-410.
[7] Gabryelska A，Lukasik ZM，Makowska JS，et al. Obstructive Sleep Apnea：From Intermittent Hypoxia to Cardiovascular Complications via Blood Platelets [J]. Front Neurol，2018，9：635.
[8] Peker Y，Carlson J，Hedner J. Increased incidence of coronary artery disease in sleep apnoea：a long-term follow-up [J]. Eur Respir J，2006，28（3）：596-602.
[9] Perk J，De Backer G，Gohlke H，et al. European Guidelines on cardiovascular disease prevention in clinical practice （version 2012）: The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice（constituted by representatives of nine societies and by invited experts） [J]. Eur Heart J，2012，33（13）：1635-1701.
[10] Jordan AS，McSharry DG，Malhotra A. Adult obstructive sleep apnoea [J]. Lancet，2014，383（9918）：736-747.
[11] Ben Ahmed H，Boussaid H，Longo S，et al. Impact of obstructive sleep apnea in recruitment of coronary collaterality during inaugural acute myocardial infarction [J]. Ann Cardiol Angeiol（Paris），2015，64（4）：273-278.
[12] Jia S，Zhou YJ，Yu Y，et al. Obstructive sleep apnea is associated with severity and long-term prognosis of acute coronary syndrome [J]. J Geriatr Cardiol，2018，15（2）：146-152.
[13] Vasheghani-Farahani A，Kazemnejad F，Sadeghniiat-Haghighi K，et al. Obstructive sleep apnea and severity of coronary artery disease [J]. Caspian J Intern Med，2018， 9（3）：276-282.
[14] Bikov A，Kolossvary M，Jermendy AL，et al. Comprehensive coronary plaque assessment in patients with obstructive sleep apnea [J]. J Sleep Res，2019，28（5）：e12828.
[15] Konishi T，Kashiwagi Y，Funayama N，et al. Obstructive sleep apnea is associated with increased coronary plaque instability：an optical frequency domain imaging study [J]. Heart Vessels，2019，34（8）：1266-1279.
[16] Gong W，Wang X，Fan J，et al. Impact of Obstructive Sleep Apnea on Platelet Function Profiles in Patients With Acute Coronary Syndrome Taking Dual Antiplatelet Therapy [J]. J Am Heart Assoc，2018，7（15）：e008808.
[17] Nakashima H，Kurobe M，Minami K，et al. Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome [J]. Eur Heart J Acute Cardiovasc Care，2015，4（1）：75-84.
[18] Jiang XM，Qian XS，Gao XF，et al. Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention [J]. Chin Med J（Engl），2018，131（9）：1023-1029.
[19] Lee CH，Sethi R，Li R，et al. Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention [J]. Circulation，2016，133（21）：2008-2017.
[20] Li Y，Yang S，Chen S，et al. Patients with symptoms and characteristics consistent with obstructive sleep apnea are at a higher risk for acute and subacute stent thrombosis after percutaneous coronary stent implantation：a single-center case-control study [J]. BMC Cardiovasc Disord，2017，17（1）：226.
[21] 周生辉，王晓，范婧尧，等.中/重度阻塞性睡眠呼吸暂停对急性心肌梗死患者预后影响的前瞻性队列研究[J].中华心血管病杂志，2018，46（8）：622-628.
[22] McEvoy RD，Antic NA，Heeley E，et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea [J]. N Engl J Med，2016，375（10）：919-931.
[23] Yu J，Zhou Z，McEvoy RD，et al. Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea：A Systematic Review and Meta-analysis [J]. JAMA，2017，318（2）：156-166.
[24] Mokhlesi B，Ayas NT. Cardiovascular Events in Obstructive Sleep Apnea - Can CPAP Therapy SAVE Lives? [J]. N Engl J Med，2016，375（10）：994-996.
[25] Peker Y，Glantz H，Eulenburg C，et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial [J]. Am J Respir Crit Care Med，2016，194（5）：613-620.
[26] 高洁，王荣国，王立立.无创持续气道正压通气对阻塞性睡眠呼吸暂停综合征患者心脏亚临床功能障碍的探究[J].中国循环杂志，2019，34（1）：72-76.
[27] Angel MGM，Francisco CR，Ferrán B，et al. Precision medicine in obstructive sleep apnoea [J] Lancet Respir Med，2019，7（5）：456-464.
2020, Vol. 17 
京公网安备 11010502046598号